Emars Perk Allen Private Limited

Emars Perk Allen Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U51909WB1977PTC031282 Incorporated 26 December 1977 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹16.71 Lakh
▼ 82% YoY
Net loss · FY 2024
₹11,222
Net margin -0.7%
EBITDA · FY 2024
₹6.81 Lakh
EBITDA margin 40.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹79.88 Lakh
Secured borrowings
Company age
49 yrs
Est. 1977
Employees · EPFO
1
Provident fund records

About Emars Perk Allen Private Limited

Data last updated:

Emars Perk Allen Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 December 1977 and has been in existence for over 49 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB1977PTC031282. Its GSTIN is 19AAACE7364G1ZI (West Bengal).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Emars Allen Pharma Private Limited and Emars Pharmaceuticals Private Limited. It is led by directors Shashanka Shekhar Sarkar (Managing Director) and Gour Pada Sarkar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 2nd Floor(South); Flat No 6; Emars Appartment 23/C Wards Institution Street, Kolkata, West Bengal, India – 700006.

As per the financials filed for FY 2024, the company reported a revenue of ₹16.71 Lakh, a decline of 82% compared to the previous year. For the same year it recorded a net loss of ₹11,222 (net margin -0.7%) and EBITDA of ₹6.81 Lakh (EBITDA margin 40.7%). Revenue has declined at a compounded annual rate (CAGR) of 52% over three years and 48% over five years.

The company has about 1 employee on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

As per MCA filings, the company has open charges of ₹79.88 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company.

Emars Perk Allen Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0040805). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909WB1977PTC031282
Registration Number 031282
Incorporation Date 26 December 1977
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0040805

Name history

Emars Perk Allen has undergone 2 name changes throughout its history. The company was previously known as Emars Allen Pharma Private Limited, and Emars Pharmaceuticals Private Limited. The current legal name is Emars Perk Allen Private Limited.

Company NameStatus
Emars Perk Allen Private LimitedCurrent
Emars Allen Pharma Private LimitedPrevious
Emars Pharmaceuticals Private LimitedPrevious

CIN history

Emars Perk Allen has one previous CIN (Corporate Identification Number): U99999WB1977PTC031282. The current CIN is U51909WB1977PTC031282, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51909WB1977PTC031282Current
U99999WB1977PTC031282Previous

Recognitions & Rankings of Emars Perk Allen

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-WB-10-0040805

Contact details

Emars Perk Allen Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    2nd Floor(South); Flat No 6; Emars Appartment 23/C Wards Institution Street, Kolkata, West Bengal, India – 700006
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Emars Perk Allen Private Limited, buy the company report.

Comprehensive company report
Emars Perk Allen Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Emars Perk Allen is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Emars Perk Allen Private Limited, buy the company report.

Financials of Emars Perk Allen Private Limited

FY 2024 filings available

Emars Perk Allen Private Limited reported revenue of ₹16.71 Lakh (down 82% YoY) for FY 2024.

Revenue · FY 2024
₹16.71 Lakh ▼ 82%
Net loss · FY 2024
₹11,222 margin -0.7%
EBITDA · FY 2024
₹6.81 Lakh margin 40.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 82%
3 years · compounded
▼ 52%
5 years · compounded
▼ 48%
EBITDA CAGR growth
1 year
▼ 79%
3 years · compounded
▲ 30%
5 years · compounded
▲ 19%

Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 82% fall in the latest year. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.81 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11,222
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin40.7%
Net Profit Margin-0.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Emars Perk Allen Private Limited, buy the company report.

Board of directors of Emars Perk Allen Private Limited

Emars Perk Allen has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gour Pada SarkarDirector01 Jan 200521 Years 10 MonthsCurrent
Shashanka Shekhar SarkarManaging Director25 Sep 200620 Years 1 MonthsCurrent

Peer comparison

Emars Perk Allen Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Unisars Health Care Private Limited₹16.98 Lakh (FY 2025)-87.0%Agra, Uttar Pradesh, India
Balaji Medware Private Limited₹16.91 Lakh (FY 2025)60.0%New Delhi, Delhi, India
A B R Drugs Private Limited₹16.75 Lakh (FY 2024)9.0%New Delhi, Delhi, India
Emars Perk Allen Private Limitedthis company₹16.71 Lakh (FY 2024)-₹11,222-0.7%-82.0%1Kolkata, West Bengal, India
Ekasar Lifesciences Private Limited₹16.68 Lakh (FY 2023)-38.0%Chandigarh, India
Ritz Pharmaceutical and Foods Products Private Limited₹16.68 Lakh (FY 2025)-41.0%Uttar Prdesh, Uttar Pradesh, India
Amaresha Pharmaceuticals Private Limited₹16.64 Lakh (FY 2024)13.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Emars Perk Allen Private Limited, buy the company report.

Auditor

Emars Perk Allen Private Limited is audited by D. K. DAS AND ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
D. K. DAS AND ASSOCIATESFY 2023332384E

Shareholding

The shareholding of Emars Perk Allen Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Emars Perk Allen Private Limited, buy the company report.

Charges & borrowings

Open charges
₹79.88 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdb Financial Services Limited₹0.45 Cr
Others₹0.35 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Aug 2019100292351Others₹34.59 LakhOpen
20 Jun 201410508910Hdb Financial Services Limited₹45.29 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Emars Perk Allen Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Emars Perk Allen has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
1
Associated companies
Key subsidiaries
Company NameCINShares held
Allen's India Ltd.U51109WB1993PLC060219

To see the full group structure of Emars Perk Allen Private Limited, buy the company report.

Employees & EPFO

Emars Perk Allen Private Limited has a workforce of 1 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.

Employee count
1
Active EPFO establishments
1
Employee growth
-92.31%

GST

Emars Perk Allen has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AAACE7364G1ZIWest BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Emars Perk Allen Private Limited, buy the company report.

Recent activity

Emars Perk Allen Private Limited has 5 board changes on record since 2005: 2 appointments and 3 cessations. The latest: Kali Pada Sarkar ceased to be Additional Director on 29 Sep 2023.

AGM
Emars Perk Allen Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Emars Perk Allen Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
Ceased
Kali Pada Sarkar ceased to be Additional Director.
Ceased
Anita Sarkar ceased to be Managing Director.
Charges
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100292351 was registered on 26 Aug 2019.
Charges
A charge with Hdb Financial Services Limited amounted to Rs. 0.45 Cr with Charge ID 10508910 was registered on 20 Jun 2014.
Ceased
Malati Sarkar ceased to be Managing Director.
Appointed
Shashanka Shekhar Sarkar was appointed as Managing Director.
Appointed
Gour Pada Sarkar was appointed as Director.
Incorporation
26 Dec 1977
Emars Perk Allen Private Limited was registered on 26 Dec 1977 with Roc Kolkata & aged 48 years 10 months as per MCA records.

Frequently asked questions

Emars Perk Allen is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 December 1977 (49+ years old) and is registered under CIN U51909WB1977PTC031282.

Emars Perk Allen has 2 current directors:

The latest financial statements of Emars Perk Allen on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Emars Perk Allen is 19AAACE7364G1ZI, registered in West Bengal.

The CIN (Corporate Identification Number) of Emars Perk Allen is U51909WB1977PTC031282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Emars Perk Allen has 3 court cases on record: 3 filed by the company. Most are in the high courts.

Emars Perk Allen was incorporated on 26 December 1977, making it 49+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Emars Perk Allen by revenue are Unisars Health Care Private Limited, Balaji Medware Private Limited, A B R Drugs Private Limited, Ekasar Lifesciences Private Limited, Ritz Pharmaceutical and Foods Products Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Kali Pada Sarkar ceased to be Additional Director on 29 Sep 2023. Anita Sarkar ceased to be Managing Director on 06 Jan 2023. Malati Sarkar ceased to be Managing Director on 01 Sep 2010. Emars Perk Allen has 5 board changes on record in total.

Yes, Emars Perk Allen is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0040805).

The registered office of Emars Perk Allen is at 2nd FloorSouth; Flat No 6; Emars Appartment 23C Wards Institution Street, Kolkata, West Bengal, India – 700006.